Medicine
Hemabate 250 mcg/1 mL injection
Hemabate 250 mcg/1 mL injection is a prescription medicine containing Carboprost for intramuscular use, marketed by Pharmacia & Upjohn, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
HEMABATE must be refrigerated at 2° to 8° C (36° to 46° F).
Key facts
- Active ingredient (INN)
- Carboprost
- Brand
- Hemabate
- Strength
- 250 mcg/1 mL
- Dosage form
- Injection
- Route
- Intramuscular
- Packs
- 1 mL, 10 ampules of 1 mL
- Marketing authorisation holder
- Pharmacia & Upjohn
- Manufacturer
- Pharmacia & Upjohn
- Origin register
- US FDA, United States
- Storage
- HEMABATE must be refrigerated at 2° to 8° C (36° to 46° F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- G02AD04 Carboprost
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 January 1979
- Identifiers
- RxCUI 213638, 238014DailyMed set ID 3d282998-ff0c-480a-bd80-155606ef0a65NDC 0009-0856Application NDA017989
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 mL in 1 ampule | 0009-0856-05 | Pharmacia & Upjohn | 9 January 1979 |
| 10 ampule in 1 package / 1 mL in 1 ampule | 0009-0856-08 | Pharmacia & Upjohn | 9 January 1979 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 9 January 1979 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Carboprost 250 mcg/1 mL injection.
Clinical summary
Carboprost is a prostaglandin analog indicated for aborting pregnancy between the 13th and 20th weeks of gestation as calculated from the first day of the last normal menstrual period and in conditions related to second trimester abortion. MedsAcross supplies Carboprost for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CarboprostFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Hemabate prescribing information (Pharmacia & Upjohn) · U.S. National Library of Medicine, DailyMed
Need Hemabate 250 mcg/1 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.